Every medication you've taken — every cancer treatment, every blood pressure pill, every COVID vaccine — went through clinical trials before it reached you. Trials are how we figure out whether something new is safe and whether it actually works. They're also how some patients get access to treatments years before they're available to everyone else.

That said, joining a trial is a serious decision. This guide walks you through what you're actually agreeing to, what to expect, and the questions worth asking before you commit.

What is a clinical trial?

A clinical trial is a research study where doctors and scientists test whether a new medical approach is safe and effective in people. “New” can mean lots of things:

  • A new drug that's never been given to humans before
  • An existing drug being tried for a new condition
  • A new medical device — e.g. a pacemaker, surgical tool, monitoring patch
  • A new combination of existing treatments
  • A new procedure, like a different way of doing surgery
  • A behavioural intervention — e.g. a dietary programme or therapy approach

Trials happen in hospitals, university medical centres, and dedicated research sites all over the world. Every trial has a principal investigator (the lead doctor responsible for the study) and a research coordinator (your main point of contact day-to-day).

The four phases

Before a drug can be approved by regulators, it has to pass through up to four phases of trials, each answering a different question.

Phase 1

Is it safe?

Tiny groups (20–80 people) to figure out safe doses and identify side effects. Often the participants are healthy volunteers. For cancer drugs, Phase 1 enrols patients when the disease is advanced.

Phase 2

Does it work?

Larger groups (100–300 people with the target condition) to see whether the drug actually does what we hoped, and to identify the right dose.

Phase 3

Is it better than what exists?

Hundreds to thousands of patients, often randomised against the current standard treatment. This is the data regulators use to approve a drug.

Phase 4

How does it perform in the real world?

Post-approval. Long-term monitoring to catch rare side effects or interactions that didn't show up in earlier phases.

You'll also occasionally see Phase 0 trials (very early, very few people, sub-therapeutic doses to study how a drug behaves in the body) and combined phaseslike “Phase 1/2” that telescope two phases into one trial.

Will I get the real drug, or a placebo?

This is one of the most common worries — and it's often overstated. Here's the reality:

  • Many trials don't use placebos at all. Single-arm trials give everyone the new treatment.
  • When placebos are used, they're typically compared against the new drug plusthe existing standard of care. The placebo arm doesn't get “nothing” — they get the current best treatment.
  • Cancer and serious-illness trials almost never use a true placebo. It would be unethical.
  • The trial must disclose whether placebos are used before you consent. If you don't see this clearly explained, ask.

Informed consent

Before you can join any trial, you must give informed consent. This is a legal document but more importantly it's a conversation. The research coordinator (or PI) walks you through:

  • What the trial is testing and why
  • Exactly what you'll be asked to do
  • Known and possible risks, including side effects
  • Possible benefits to you (often, none beyond the standard of care)
  • Alternative treatments you could choose instead
  • How your data is handled and kept confidential
  • Compensation, if any
  • That you can withdraw at any time, no penalty

Take the consent form home. Ask your doctor or family to read it with you. Bring a list of questions to the next visit. You are notbeing pushy by asking questions — a good coordinator wants you to fully understand what you're signing up for.

Your rights as a participant

Clinical trials are heavily regulated to protect participants. Among other things, you have the right to:

  • Withdraw at any time. No reason needed, no penalty, no impact on your other medical care.
  • Be told about new risks. If something changes mid-trial that affects your safety, the team must inform you and offer you the chance to re-consent or leave.
  • Receive your individual results, usually after the trial finishes (timing varies — confirm with the coordinator).
  • Privacy. Your data is anonymised in published results. Insurance companies cannot generally access trial records.
  • An independent ethics review. Every trial is overseen by an Institutional Review Board (IRB) or Ethics Committee that protects participants.

Eligibility — and why it's strict

Every trial has long lists of inclusion criteria (what you must have to qualify) and exclusion criteria (what disqualifies you). These can feel arbitrary, but they exist for two reasons:

  • Safety: ruling out conditions that might make the drug dangerous for you specifically
  • Clarity of results: if everyone in the trial has slightly different disease characteristics, the data gets noisy and answers are harder to find

Don't be discouraged if you don't qualify for one trial. There may be others looking for someone exactly like you. Tools like our eligibility wizard check multiple trials at once.

What does it cost?

The trial drug or device itself is almost always free. The sponsor pays for it. What may not be covered:

  • Standard care that you'd be paying for anyway (your normal doctor visits, scans, labs)
  • Travel to the trial site, parking, accommodation
  • Time off work for visits

Some trials reimburse travel and lost wages. Some patient assistance programs cover travel for patients in distant cities. Ask the coordinator about financial assistance— many trial budgets include this and they'll happily share what's available.

How to decide whether a trial is right for you

There's no universal answer. But these questions help focus the decision:

  1. Is the standard treatment working for you?If yes, the case for a trial is weaker. If no, trials open access to options that aren't yet on the market.
  2. What's the time commitment? Some trials need weekly visits for months. Others are one-and-done. Be honest about what you can do.
  3. How does your doctor feel? Your treating physician knows your case best. Most are supportive of trials — but if they raise concerns, listen.
  4. What's the realistic benefit?Phase 1 trials rarely cure anyone — they're mostly safety tests. Phase 3 trials of new cancer drugs can sometimes mean meaningful extension of life. Be clear-eyed about what to expect.
  5. What's your gut say? Some patients want every option, fast. Others prefer the proven path. Both are valid.

Common myths to retire

“Trials are only for desperate cases.”

False. Trials run at every stage — early disease, prevention, even prevention in healthy people. Many patients enter trials early, while options are still wide.

“If I join a trial I become a guinea pig.”

Misleading. Modern trials are extensively reviewed before they start. You'll receive more medical attention than standard care patients — frequent vitals, imaging, blood work. Many participants describe it as the most carefully monitored period of their treatment.

“If a trial drug works, I'll be cut off when it ends.”

Often false. Most sponsors continue providing the drug after the trial closes through “open-label extension” or compassionate use programs, especially when it's clearly benefiting you. Ask in advance.

Next steps

If you're thinking about a trial:

  1. Search trials for your condition on Clinical Trial Compass or ClinicalTrials.gov.
  2. Use our eligibility wizard to quickly rule trials in or out.
  3. Read the criteria for the trials that look promising. Ask AI to translate them.
  4. Send a screening request to coordinators of trials you're “likely eligible” for — you can do this through Compass.
  5. Bring our list of questions to your screening call.
  6. Discuss your top 1–2 candidates with your treating physician.
  7. If everything feels right, sign the informed consent. If not, walk away.

Clinical trials are one of the most powerful options patients have — but only if they fit your situation. Take your time. Ask questions. The right trial for you may be the one that, in five years, becomes the new standard treatment for someone else with your diagnosis.

Not medical advice. This guide is informational only. Always discuss treatment decisions with your healthcare provider. Trial eligibility is determined by the trial coordinator, not by Compass.